Effects of methylprednisolone on the GABA-and glutamate-induced currents: Relevance to glucocorticoid-induced neurotoxicity and brain aging

Steroids

Volumn 61, Issue 6, 1996, Pages 354-366

  Foroutan, Ahmad ^a   Behbehan, Michael M ^a   Anderson, D K ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cell culture; Methylprednisolone; Neurotoxicity; Patch clamp; Spinal cord

Indexed keywords

MURINAE;

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; METHYLPREDNISOLONE;

AGING; ARTICLE; BRAIN; EMBRYO; EXCITATORY POSTSYNAPTIC POTENTIAL; MOUSE; NEUROTOXICITY; NONHUMAN; PATCH CLAMP; SPINAL CORD; SYNAPTIC TRANSMISSION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC CONDUCTIVITY; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUCOCORTICOIDS; GLUTAMIC ACID; MEMBRANE POTENTIALS; METHYLPREDNISOLONE; MICE; NEURONS; NEUROPROTECTIVE AGENTS; PATCH-CLAMP TECHNIQUES; SPINAL CORD; SYNAPTIC TRANSMISSION;

EID: 0029996583     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0039-128X(96)00041-4     Document Type: Article

References (31)

1. Mackinnon SE, Hudson AR, Gentili F, Kline DG, Hunter RT (1982). Peripheral nerve injection injury with steroid agents. Plast Reconstr Surg 69:482-489.
2. Sapolsky RM (1985). Glucocorticoid toxicity in the hippocampus: Temporal aspects of neuronal vulnerability. Brain Res 359:300-305.
3. Sapolsky RM (1994). The physiological relevance of glucocorticoid endangerment of the hippocampus. Ann NY Acad Sci 746:294-307.
4. Baethge BA, Lidsky MD, Goldberg JW (1992). A study of adverse effects of high-dose intravenous (pulse) methylprednisolone therapy in patients with rheumatic disease. Ann Pharmacother 26:316-320.
5. Suchman AL, Condemi JJ, Leddy JP (1983). Seizure after pulse therapy with methylprednisolone (editorial). Arthritis Rheum 26: 117.
6. Whitworth JA (1992). Adrenocorticotrophin and steroid-induced hypertension in humans. Kidney Int 41(Suppl. 37):S-34-S-37.
7. A receptor. Neuroscience 45:121-135.
8. Hunt P, Clements-Jewery S (1981). A steroid derivative, R 5135, antagonizes the GABA/benzodiazepine receptor interaction. Neuropharmacology 20:357-361.
9. Paul SM, Purdy RH (1992). Neuroactive steroids. FASEB J 6:2311-2322.
10. Mellon SH (1994). Neurosteroids: biochemistry, mode of action, and clinical relevance. J Clin Endocrinol Metab 78:1003-1008.
11. Wu F, Gibbs TT, Farb DH (1991). Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol Pharmacol 40:333-336.
12. ++ responses: structure-activity studies. J Pharmacol Exp Ther 271:677-682.
13. 3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc Natl Acad Sci USA 92:3774-3778.
14. Erdo S, Michler A, Wolff J R (1991). GABA accelerates excitotoxic cell death in cortical cultures: protection by blockers of GABA-gated chloride channels. Brain Res 542:254-258.
15. Samochocki M, Strosznajder J (1994). Age-related changes of GABA-activated chloride channel properties in brain cortex synaptic plasma membrane: evidence for phospholipase involvement. Neurochemistry 63:1422-1528.
16. Bracken MB, Shepard MJ, Collins WF, Holford TR, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon JC, Marshall LF, Perot PL, Piepmeier J, Sonntag VKH, Wagner FC, Wilberger JL, Winn HR, Young W (1992). Methylprednisolone and naloxone treatment after acute spinal cord injury: 1-year follow-up data. J Neurosurg 76:23-31.
17. Hall ED (1981). Direct action of the glucocorticoids on motor neurons: relevance to neuromuscular disease. In: Lee HJ, Fitzgerald TJ (eds), Progress in Research and Clinical Applications of Corticosteroids. Heyden and Sons, London, pp. 268-286.
18. Haughey DB, Jusko WJ (1992). Bioavailability and nonlinear disposition of methylprednisolone and methylprednisone in the rat. J Pharm Sci 81:117-121.
19. Nelson DA (1993). Intraspinal therapy using methylprednisolone acetate: twenty-three years of clinical controversy. Spine 18:278-286.
20. Bocanegra TS, Castaneda MO, Espinoza LR, Vasy FB, Germain BF (1981). Sudden death after methylprednisolone pulse therapy (abstract). Ann Int Med 95:122.
21. Garrett R, Paulus H (1980). Complications of intravenous methylprednisolone pulse therapy (abstract). Arthritis Rheum 23:677.
22. Nelson DA (1991). Further warnings from Australia concerning intraspinal steroids (editorial). Arch Neurol 48:259.
23. Abram SE, Marsala M, Yaksh TL (1994). Analgesic and neurotoxic effects of intrathecal corticosteroids in rats. Anesthesiology 81: 1198-1205.
24. Koyoma S (1986). Effects of methylprednisolone on renal nerve response to stimulation of medullary pressor area in endotoxin-induced hypotension. Circ Shock 20:205-215.
25. Parkhurst RD, Gutai JP, Bacon GE, Kokenakes S (1971). Comparison of plasma and cerebrospinal fluid levels of steroid analogues following intravenous and intrathecal injection in dogs. Neurology 21:906-910.
26. Rosenberg-Schaffer LJ, Lucas JH (1993). An in vitro study of the effects of methylprednisolone on lesioned and uninjured mammalian spinal neurons. Brain Res 605:327-331.
27. Uhler TA, Firm DM, Pakzaban P, Isacson O (1994). The effects of megadose methylprednisolone and U-78517F on toxicity mediated by glutamate receptors in the rat neostriatum. Neurosurgery 34:122-128.
28. Yoon K (1994). Voltage-dependent modulation of GABAA receptor channel desensitization in rat hippocampal neurons. J Neurophysiol 71:2151-2160.
29. Nelson PG, Ransom BR, Henkart M, Bullock PN (1977). Mouse spinal cord in cell culture. IV. Modulation of inhibitory synaptic function. J Neurophysiol 40:1178-1187.
30. Olney JW (1994). New mechanisms of excitatory transmitter neurotoxicity. J Neural Transm 43(Suppl):47-51.
31. Choi DW (1994). Glutamate receptors and the induction of excitotoxic neuronal death. Prog Brain Res 100:47-51.